JD023
/ Beijing JD Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 11, 2024
Off-the-shelf CD123 CAR-NK for R/R AML
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Peking University People's Hospital
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
October 26, 2022
Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD123
October 11, 2022
Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD123
1 to 3
Of
3
Go to page
1